Am J Transplant, Volume 20, Suppl 3 Archives - Page 205 of 223 - ATC Abstracts

2020 American Transplant Congress
Muscle Strength and Physical Functioning in Pediatric Kidney Transplant Recipients
K. Sgambat, K. Amatya, A. Moudgil
Nephrology, Children's National, Washington, DC
*Purpose: Children with end stage renal disease on dialysis are known to be at high risk for protein energy wasting and low muscle mass, however…
2020 American Transplant Congress
Free Fatty Acids and Delayed Graft Function after Kidney Transplantation: A Single Center Analysis
J. Zhou¹, J. Lyu¹, X. Yu¹, C. Wu², J. Chen¹
¹The First Affiliated Hospital Kidney Disease Center, College of Medicine, Zhejiang University, Hangzhou, China, ²Global Health Research Center, Duke Kunshan University, Kunshan, China
*Purpose: Delayed graft function (DGF) is one of the most common obstacles of donation after circulatory death (DCD) kidney transplantation. Serum free fatty acids (FFAs)…
2020 American Transplant Congress
Cigarette Smoking and Long-Term Renal Function and Cardiovascular Disease in Living Kidney Donors
S. Getsin¹, M. Waldram¹, Y. Yu¹, D. Brennan¹, F. Al Ammary¹, J. Garonzik-Wang¹, M. Henderson¹, J. Locke², R. Reed², K. Lentine³, D. Segev¹, A. Massie¹
¹Johns Hopkins School of Medicine, Baltimore, MD, ²University of Alabama at Birmingham School of Medicine, Birmingham, AL, ³Saint Louis University School of Medicine, St. Louis, MO
*Purpose: Since cigarette smoking is a major risk factor for kidney and cardiovascular disease in the general population, many programs advise living kidney donor candidates…
2020 American Transplant Congress
Delayed Introduction of Mammalian Inhibitors of Rapamycin (mTOR) Post Kidney Transplantation Might Avoid the Chronic Nephrotoxicity of Calcineurin Inhibitors. Herein We Are Reporting an Eight-Years Single Center Experience of mTOR-Based Immunosuppression Regimen in Comparison with Cyclosporin-Based Regimen
W. A. Hassan¹, H. M. Tawfik²
¹Medicine-Nephrology, University of Tennessee Health Science Center, Memphis, TN, ²Medicine-Nephrology, Minia Nephrology Hospital, Minia University, Minia, Egypt
*Purpose: Delayed introduction of mTOR inhibitors post kidney transplantation might avoid the chronic nephrotoxicity of CNI: eight-years single center experience.*Methods: This is a retrospective analysis…
2020 American Transplant Congress
Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Treatment of Patients with Hepatitis B Following Liver Transplantation
C. Cheng
Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Kwei-Shan Township, Taoyuan, Taiwan
*Purpose: Taiwan has a high prevalence of hepatitis B (HBV) and HBV related end-stages liver diseases are the leading causes of liver transplantation (LT). Tenofovir…
2020 American Transplant Congress
Re-Transplantation Outcomes in the United States Before and after DAA-Introduction
T. Ivanics, M. Rizzari, A. Al-Kurd, T. Kitajima, A. Elsabbagh, K. Collins, A. Yoshida, M. Abouljoud, S. Nagai
Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: The success of direct-acting antiviral (DAA) therapy has led to the widespread treatment of HCV and near-universal cure for chronically infected patients and improved…
2020 American Transplant Congress
Atrial Fibrillation Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort
M. German¹, A. Hristov¹, A. Lee¹, F. Osman¹, A. Kwong², D. Devuni³, C. Wang⁴, J. Boike⁵, J. Jo⁵, L. VanWagner⁵, M. Serper⁶, R. Sharma⁷, E. Verna⁷, J. Shor³, A. Koteish⁸, G. Sehmbey⁹, A. Seetharam⁹, N. John², Y. Patel¹⁰, M. Kappus¹⁰, T. Couri¹¹, S. Paul¹¹, R. Salgia¹², Q. Nhu¹³, C. Frenette¹³, J. Lai⁴, A. Goel², E. Spengler¹
¹U of Wisconsin, Madison, WI, ²Stanford, Palo Alto, CA, ³U of Massachusetts, Worcester, MA, ⁴U of California, San Francisco, CA, ⁵Northwestern, Chicago, IL, ⁶U of Pennsylvania, Philadelphia, PA, ⁷Columbia, New York, NY, ⁸Florida Hospital, Orlando, FL, ⁹U of Arizona, Phoenix, AZ, ¹⁰Duke, Durham, NC, ¹¹U of Chicago, Chicago, IL, ¹²Henry Ford Hospital, Detroit, MI, ¹³Scripps, San Diego, CA
*Purpose: More liver transplants (LT) are being performed in patients >65 years (y) - a population with higher rates of cardiovascular (CV) disease. It is…
2020 American Transplant Congress
Risk Factors of Invasive Fungal Infections in Liver Transplantation: Systematic Review and Meta-Analysis
P. Phoompoung¹, S. Herrera², A. Perez Cortes Villalobos¹, F. Foroutan¹, A. Orchanian-Cheff¹, S. Husain¹
¹University Health Network, Toronto, ON, Canada, ²Hospital Universitario Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain
*Purpose: Invasive fungal infection (IFI) remains one of the most common infectious complications after solid organ transplantation. Liver transplant recipients (LTRs) have a higher mortality…
2020 American Transplant Congress
Clinical Correlation of Results of s CD4/CD8 Cytomegalovirus Cell Mediated Immunity Test with Incidence of Cytomegalovirus Infection
M. Jorgenson¹, M. Hillis¹, C. Saddler², J. Smith², D. Mandelbrot²
¹UW Health, Madison, WI, ²UWMF, Madison, WI
*Purpose: The purpose of this study was to evaluate the predictive potential of a CD4/CD8 flow cytometric cell mediated immunity (CMI) assay for the development…
2020 American Transplant Congress
Epstein-Barr Virus (EBV)+ Post-Transplant Lymphoproliferative Disorder (PTLD) is Associated with Tumor CCL3/CCL4 Expression and an Increase in Tumor-Infiltrating Monocytes
J. Toh¹, F. Vallania¹, W. A. Haynes¹, G. Bhagat², F. E. Craig³, S. H. Swerdlow⁴, T. Tousseyn⁵, S. M. Krams¹, P. Khatri¹, O. M. Martinez¹
¹Stanford University School of Medicine, Stanford, CA, ²Columbia University Medical Center, New York City, NY, ³Mayo Clinic College of Medicine, Phoenix, AZ, ⁴University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁵Katholieke Universiteit Leuven, Leuven, Belgium
*Purpose: PTLD is a serious post-transplant complication that encompasses a spectrum of abnormal lymphoproliferations, including B cell lymphoma-type PTLDs. Although many are EBV-driven, a significant…